Manulife (Manufacturers Life Insurance)
KALV

Manulife (Manufacturers Life Insurance)’s KalVista Pharmaceuticals KALV Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Sell
10,551
-1,272
-11% -$20.5K ﹤0.01% 2443
2025
Q4 		$191K Sell
11,823
-1,465
-11% -$19.4K ﹤0.01% 2548
2025
Q3 		$162K Sell
13,288
-1,338
-9% -$18.5K ﹤0.01% 2650
2025
Q2 		$165K Buy
14,626
+818
+6% +$10K ﹤0.01% 2631
2025
Q1 		$159K Sell
13,808
-385
-3% -$3.93K ﹤0.01% 2567
2024
Q4 		$120K Sell
14,193
-709
-5% -$7.34K ﹤0.01% 2781
2024
Q3 		$173K Sell
14,902
-535
-3% -$6.73K ﹤0.01% 2716
2024
Q2 		$182K Buy
15,437
+3,314
+27% +$38.7K ﹤0.01% 2639
2024
Q1 		$144K Sell
12,123
-774
-6% -$10.3K ﹤0.01% 2691
2023
Q4 		$158K Buy
12,897
+2,270
+21% +$20.7K ﹤0.01% 2702
2023
Q3 		$102K Hold
10,627
– – ﹤0.01% 2798
2023
Q2 		$95.6K Buy
+10,627
New +$98K ﹤0.01% 2862
2022
Q4 		– Sell
-10,156
Closed -$147K – 2983
2022
Q3 		$147K Sell
10,156
-358
-3% -$5K ﹤0.01% 2699
2022
Q2 		$103K Buy
+10,514
New +$116K ﹤0.01% 2897
2022
Q1 		– Sell
-11,560
Closed -$153 – 3132
2021
Q4 		$153 Buy
11,560
+313
+3% +$4.98K ﹤0.01% 2981
2021
Q3 		$196K Sell
11,247
-474
-4% -$9.61K ﹤0.01% 2995
2021
Q2 		$281K Buy
11,721
+709
+6% +$18.5K ﹤0.01% 2858
2021
Q1 		$283K Buy
+11,012
New +$289K ﹤0.01% 2657
2018
Q3 		– Sell
-231
Closed -$2K – 3440
2018
Q2 		$2K Hold
231
– – ﹤0.01% 4205
2018
Q1 		$2K Hold
231
– – ﹤0.01% 4230
2017
Q4 		$2K Hold
231
– – ﹤0.01% 4222
2017
Q3 		$2K Sell
231
-75
-25% -$535 ﹤0.01% 4118
2017
Q2 		$3K Sell
306
-4
-1% -$29 ﹤0.01% 4048
2017
Q1 		$3K Hold
310
– – ﹤0.01% 3872
2016
Q4 		$3K Sell
310
-2
-0.6% -$15 ﹤0.01% 4044
2016
Q3 		$2K Hold
312
– – ﹤0.01% 4066
2016
Q2 		$3K Buy
312
+47
+18% +$544 ﹤0.01% 3933
2016
Q1 		$3K Buy
265
+185
+231% +$3.32K ﹤0.01% 3871
2015
Q4 		$4 Hold
80
– – ﹤0.01% 3701
2015
Q3 		$4 Hold
80
– – ﹤0.01% 3725
2015
Q2 		$8 Buy
+80
New +$7.94K ﹤0.01% 3597

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s KALV Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its KalVista Pharmaceuticals (KALV) stake by 11% in Q1 2026, selling an estimated $20.5K and leaving 10,551 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #2443.

Manulife (Manufacturers Life Insurance) first reported a position in KALV in Q2 2015 and has held it in 31 quarters since. The position peaked at $283K in Q1 2021. 184 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 10,551 shares of KalVista Pharmaceuticals worth $212K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,272 KalVista Pharmaceuticals shares in Q1 2026, an estimated $20.5K.
  • KalVista Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2443 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in KalVista Pharmaceuticals in Q2 2015 and has held it in 31 quarters since.
  • Manulife (Manufacturers Life Insurance)'s KalVista Pharmaceuticals position peaked at $283K in Q1 2021.
  • 184 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.